Anaerobic bacteremia

被引:107
作者
Goldstein, EJC
机构
[1] UNIV CALIF LOS ANGELES, MED CTR, RM ALDEN RES LAB, SANTA MONICA, CA USA
[2] UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA USA
关键词
D O I
10.1093/clinids/23.Supplement_1.S97
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The results of early studies showed that anaerobes accounted for 20% of an bacteremias; more-recent data suggest that these organisms account for similar to 4% (0.5%-9%) of bacteremias (or approximately one case per 1,000 admissions), with variation by geographic location, hospital patient demographics, and especially, patient age. Elderly persons seem to be at increased risk for developing anaerobic bacteremia while young children (2-5 years of age) are at the least risk. Bacteroides fragilis is the most common blood isolate recovered from patients with anaerobic bacteremia; this organism and species of the B. fragilis group account for similar to 55% of anaerobic bacteremias. B. fragilis bacteremia is associated with a mortality of 19%, with a mortality risk of 3.2; a 16-day increase in hospital stay; and often, intra-abdominal disease. Associated risks for mortality include chronic liver disease and congestive heart failure. There is value in performing separate anaerobic blood cultures; clinicians at each institution should determine the prevalence of anaerobic bacteremia and use this information to guide blood-culture practices.
引用
收藏
页码:S97 / S101
页数:5
相关论文
共 43 条
[1]   IDENTIFICATION AND ANTIMICROBIAL RESISTANCE PATTERNS OF CLINICAL ISOLATES OF CLOSTRIDIUM-CLOSTRIDIOFORME, CLOSTRIDIUM-INNOCUUM AND CLOSTRIDIUM-RAMOSUM COMPARED WITH THOSE OF CLINICAL ISOLATES OF CLOSTRIDIUM-PERFRINGENS [J].
ALEXANDER, CJ ;
CITRON, DM ;
BRAZIER, JS ;
GOLDSTEIN, EJC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (12) :3209-3215
[2]  
[Anonymous], MMWR
[3]  
[Anonymous], 1977, Anaerobic Bacteria in Human Disease
[4]   BETA-LACTAMASE PRODUCTION AND SUSCEPTIBILITIES TO AMOXICILLIN, AMOXICILLIN-CLAVULANATE, TICARCILLIN, TICARCILLIN-CLAVULANATE, CEFOXITIN, IMIPENEM, AND METRONIDAZOLE OF 320 NON-BACTEROIDES-FRAGILIS-BACTEROIDES ISOLATES AND 129 FUSOBACTERIA FROM 28 UNITED-STATES CENTERS [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) :1546-1550
[5]   ANAEROBE-INDUCED BACTEREMIA IN ITALY - A NATIONWIDE SURVEY [J].
ARZESE, A ;
TREVISAN, R ;
MENOZZI, MG ;
AMATO, G ;
BARON, F ;
BRAGA, A ;
CUCCURULLO, S ;
GUERRA, C ;
MEYER, R ;
NICOLETTI, P ;
ORTISI, G ;
PIACENTINI, I ;
PITZUS, E ;
POSTIGLIONE, A ;
SERRA, M ;
TOSETTI, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 :S230-S232
[6]   SUSCEPTIBILITY PATTERNS AND RESISTANCE TO IMIPENEM IN THE BACTEROIDES-FRAGILIS GROUP SPECIES IN JAPAN - A 4-YEAR STUDY [J].
BANDOH, K ;
UENO, K ;
WATANABE, K ;
KATO, N .
CLINICAL INFECTIOUS DISEASES, 1993, 16 :S382-S386
[7]   ANAEROBIC BACTERIAL BACTEREMIA - 12-YEAR EXPERIENCE IN 2 MILITARY HOSPITALS [J].
BROOK, I .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) :1071-1075
[9]   BACTEROIDACEAE BACTEREMIA - CLINICAL EXPERIENCE WITH 112 PATIENTS [J].
CHOW, AW ;
GUZE, LB .
MEDICINE, 1974, 53 (02) :93-126
[10]   EVALUATION OF THE E-TEST FOR SUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA [J].
CITRON, DM ;
OSTOVARI, MI ;
KARLSSON, A ;
GOLDSTEIN, EJC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (10) :2197-2203